Yajing Feng
Zhengzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Addition of angiogenesis inhibitors to CDK4/6 inhibitors and fulvestrant in hormone receptor-positive, HER2-negative advanced breast cancer.
Journal: Chinese medical journal
Published: December 06, 2025
Inetetamab plus camrelizumab and utidelone for pretreated HER2-positive advanced breast cancer: a prospective, single-arm, phase 2 study.
Journal: BMC medicine
Published: October 15, 2025
Utidelone Plus Bevacizumab for ERBB2-Negative Metastatic Breast Cancer and Active Brain Metastases: The U-BOMB Phase 2 Nonrandomized Clinical Trial.
Journal: JAMA oncology
Published: June 26, 2025
Analysis of mortality trends and projected burden of digestive system cancer in China: a nationwide longitudinal analysis (2006-2020) with mortality forecasts to 2045.
Journal: Discover oncology
Published: April 07, 2025
Prognostic value of lncRNA AFAP1-AS1 in breast cancer: a meta-analysis and validated study in Chinese population.
Journal: Cancer reports (Hoboken, N.J.)
Published: May 09, 2023
Dalpiciclib and pyrotinib in women with HER2-positive advanced breast cancer: a single-arm phase II trial.
Journal: Nature communications
Published: February 19, 2023
Recent insights into autophagy and metals/nanoparticles exposure.
Journal: Toxicological research
Published: September 24, 2022
Increased lncRNA AFAP1-AS1 expression predicts poor prognosis in gastric cancer: Evidence from published studies and followed up verification.
Journal: Cancer medicine
Published: April 01, 2022
PM2.5 exposure induces reproductive injury through IRE1/JNK/autophagy signaling in male rats.
Journal: Ecotoxicology and environmental safety
Published: August 28, 2020
Prognostic values of microRNA-130 family expression in patients with cancer: a meta-analysis and database test.
Journal: Journal of translational medicine
Published: May 21, 2019
Last Updated: 09/26/2026